The project – which is being funded by academic-industry partnership group METRC – will see the contract manufacturing organisation (CMO) work with researchers from the Universities of Durham and Leeds investigate processes that will improve cost efficiencies and increase capacity.
Specifics of the deal were not disclosed, although the general aim is to find new and improved ways of producing active pharmaceutical ingredients (API) by focusing on optimising flow processes and kinetics.
The partnership is the second agreement the CMO has announced since it formed its Aesica Innovation Board (AIB) to try and bridge the gap between cutting edge R&D and commercial application earlier this year.
Outsourcing-pharma.com spoke with Alan Raymond from Aesica and Dr Riddhi Shukla from the Centre for Pharmaceutical Engineering Science at the University of Bradford at CPhI in Madrid last year who set out the rationale for this type of collaboration.